In fact, a recent systematic review and meta-analysis validated the effect of anti –TNF-α drugs in improving depression symptoms, and associated the antidepressant effect with baseline symptom severity (Kappelmann et al., 2016). The gene discussed is TNF; the disease is depressive symptom measurement.